Preserved Ratio Impaired Spirometry in US Primary Care Patients Diagnosed with Chronic Obstructive Pulmonary Disease

Overview

Journal Pragmat Obs Res

Publisher Dove Medical Press

Specialty General Medicine

Date 2024 Dec 18

PMID 39691636

Authors

Alexander Evans

Yasir Tarabichi

Wilson D Pace

Barry Make

Nicholas Bushell

Victoria Carter

Ku-Lang Chang

Chester Fox

MeiLan K Han

Alan Kaplan

Janwillem W H Kocks

Chantal Le Lievre

Alexander Roussos

Neil Skolnik

Joan B Soriano

Barbara P Yawn

David Price

Affiliations

Soon will be listed here.

Abstract

Background: Preserved ratio impaired spirometry (PRISm) represents a population with spirometry results that do not meet standardized COPD obstruction criteria, yet present with high respiratory symptom burden and might benefit from respiratory management and treatment. We aimed to determine prevalence of PRISm in US primary care patients diagnosed with COPD, describe their demographic, clinical, and CT scan characteristics.

Methods: An observational registry study utilizing the US APEX COPD registry, composed of patients diagnosed with COPD aged 35+ years. Demographic and clinical data were collected from EHRs and complemented by questionnaires. Multivariable logistic regression was performed to assess whether PRISm predicts lung function decline.

Results: Prevalence of PRISm within a primary care population clinically diagnosed with COPD was 23.6% (678/2866, 95% CI 22.0-25.1). Those with PRISm were more likely female (55.9% vs 46.9%), younger (66.3±11.1 vs 69.2±10.3 years), with a greater mean BMI (33.5±9.2 vs 27.8±7.2 kg/m), more often African American or Hispanic (37.2% vs 26.3%), and with fewer current smokers (33.1% vs 36.8%) when compared to those meeting COPD spirometry criteria (all p<0.05). Compared to COPD GOLD 0 patients, individuals with PRISm had greater BMI (33.5±9.2 vs 30.6±7.8), and were more likely current smokers (33.1% vs 23.4%), both p<0.05. Patients with PRISm had similar respiratory symptoms (chronic bronchitis, CAT, and mMRC) to overall COPD patients, but more frequently than GOLD 0 COPD patients (p<0.01). Emphysema was more commonly reported in CT scans from patients with PRISm 70.3% (260/369, 95% CI 65.8-75.3) than those with GOLD 0 COPD 64.1% (218/340, 95% CI 58.8-69.2) (p<0.05). PRISm status was not predictive of lung function decline.

Interpretation: One in four primary care patients with clinically diagnosed COPD in a large US registry fulfil the spirometric definition of PRISm rather than COPD, but suffers from emphysema in CT and significant respiratory symptoms.

References

Yawn B, Kaplan A, Pace W, Kocks J, Bulathsinhala L, Carter V . Advancing the Patient EXperience (APEX) in COPD Registry: Study Design and Strengths. J Am Board Fam Med. 2021; 34(1):22-31. DOI: 10.3122/jabfm.2021.01.200351. View

Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I . Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022; 10(5):447-458. PMC: 9050565. DOI: 10.1016/S2213-2600(21)00511-7. View

Zheng J, Zhou R, Zhang Y, Su K, Chen H, Li F . Preserved Ratio Impaired Spirometry in Relationship to Cardiovascular Outcomes: A Large Prospective Cohort Study. Chest. 2022; 163(3):610-623. DOI: 10.1016/j.chest.2022.11.003. View

Wan E, Castaldi P, Cho M, Hokanson J, Regan E, Make B . Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014; 15:89. PMC: 4256936. DOI: 10.1186/s12931-014-0089-y. View

Adibi A, Sadatsafavi M . Looking at the COPD spectrum through "PRISm". Eur Respir J. 2020; 55(1). DOI: 10.1183/13993003.02217-2019. View

Lowe K, Regan E, Anzueto A, Austin E, Austin J, Beaty T . COPDGene 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis. 2019; 6(5):384-399. PMC: 7020846. DOI: 10.15326/jcopdf.6.5.2019.0149. View

Mannino D, McBurnie M, Tan W, Kocabas A, Anto J, Vollmer W . Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis. 2012; 16(10):1405-11. DOI: 10.5588/ijtld.12.0054. View

Hankinson J, Odencrantz J, Fedan K . Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999; 159(1):179-87. DOI: 10.1164/ajrccm.159.1.9712108. View

Schermer T, Robberts B, Crockett A, Thoonen B, Lucas A, Grootens J . Should the diagnosis of COPD be based on a single spirometry test?. NPJ Prim Care Respir Med. 2016; 26:16059. PMC: 5041590. DOI: 10.1038/npjpcrm.2016.59. View

10.

Krishnan S, Tan W, Farias R, Aaron S, Benedetti A, Chapman K . Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study. Chest. 2023; 164(3):637-649. DOI: 10.1016/j.chest.2023.02.045. View

11.

Bakke P, Ronmark E, Eagan T, Pistelli F, Annesi-Maesano I, Maly M . Recommendations for epidemiological studies on COPD. Eur Respir J. 2011; 38(6):1261-77. DOI: 10.1183/09031936.00193809. View

12.

Lee T, Bartle B, Weiss K . Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006; 129(6):1509-15. DOI: 10.1378/chest.129.6.1509. View

13.

Alqahtani J, Oyelade T, Aldhahir A, Alghamdi S, Almehmadi M, Alqahtani A . Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020; 15(5):e0233147. PMC: 7213702. DOI: 10.1371/journal.pone.0233147. View

14.

Jones R, Price D, Ryan D, Sims E, von Ziegenweidt J, Mascarenhas L . Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med. 2014; 2(4):267-76. DOI: 10.1016/S2213-2600(14)70008-6. View

15.

Price D, Crockett A, Arne M, Garbe B, Jones R, Kaplan A . Spirometry in primary care case-identification, diagnosis and management of COPD. Prim Care Respir J. 2009; 18(3):216-23. PMC: 6619278. DOI: 10.4104/pcrj.2009.00055. View

16.

Edwards C, Kaplan A, Yawn B, Kocks J, Bulathsinhala L, Carter V . Development of the Advancing the Patient Experience in COPD Registry: A Modified Delphi Study. Chronic Obstr Pulm Dis. 2020; 8(1). PMC: 8047610. DOI: 10.15326/jcopdf.2020.0154. View

17.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7. DOI: 10.1016/S0140-6736(07)61602-X. View

18.

Kim J, Lee C, Lee H, Kim H . Association between Comorbidities and Preserved Ratio Impaired Spirometry: Using the Korean National Health and Nutrition Examination Survey IV-VI. Respiration. 2021; 101(1):25-33. PMC: 8820418. DOI: 10.1159/000517599. View

19.

Fox C, Pace W, Brandt E, Carter V, Chang K, Edwards C . Variation in Demographic and Clinical Characteristics of Patients with COPD Receiving Care in US Primary Care: Data from the Advancing the Patient EXperience (APEX) in COPD Registry. Pragmat Obs Res. 2022; 13:17-31. PMC: 9064065. DOI: 10.2147/POR.S342736. View

20.

He D, Sun Y, Gao M, Wu Q, Cheng Z, Li J . Different Risks of Mortality and Longitudinal Transition Trajectories in New Potential Subtypes of the Preserved Ratio Impaired Spirometry: Evidence From the English Longitudinal Study of Aging. Front Med (Lausanne). 2021; 8:755855. PMC: 8631955. DOI: 10.3389/fmed.2021.755855. View